In 2014, Amgen sued Sanofi and Regeneron to claim ownership of an entire class of cholesterol drugs. Nine years later, the Supreme Court ruled against them - but they won where it mattered most.
Enjoyed this read. Very curious that Amgen was able to remain the market leader in this space too. The subtle quip in the industry is that Amgen is a lawfirm disguised as a biotech company, and this story is a great example.
This was such a great read - problems clearly articulated with an amazing case study and some practical solutions at the end. Love it!
Enjoyed this read. Very curious that Amgen was able to remain the market leader in this space too. The subtle quip in the industry is that Amgen is a lawfirm disguised as a biotech company, and this story is a great example.